Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Ãåìàòîëîãèÿ è òðàíñôóçèîëîãèÿ

 
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #1  
Ñòàðûé 02.07.2007, 22:54
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,637
Ïîáëàãîäàðèëè 33,354 ðàç(à) çà 31,699 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Æåëåçîäåôèöèòíûå íîâîñòè

Óâàæàåìûå êîëëåãè,

Ýòèì ñîîáùåíèåì îòêðûâàþ íîâóþ òåìó, ãäå áóäó ðàçìåùàòü òåçèñû íåäàâíèõ ïóáëèêàöèé ïî æåëåçîäåôèöèòó èëè ÆÄ àíåìèè, èìåþùèå îïðåäåëåííûé êëèíè÷åñêèé èíòåðåñ. Íà÷íó ñ ðàáîòû èç Øâåéöàðèè îò èçâåñòíîãî ñïåöèàëèñòà, ðàáîòû êîòîðîãî ïîñâÿùåíû èçó÷åíèþ ñâÿçè æåëåçîäåôèöèòà è íàðóøåíèþ ôóíêöèè ùèòîâèäíîé æåëåçû:

J Clin Endocrinol Metab. 2007 Jun 12;
Iron deficiency predicts poor maternal thyroid status during pregnancy.
Zimmermann MB, Burgi H, Hurrell RF.
Laboratory for Human Nutrition, Swiss Federal Institute of Technology (ETH) Zürich; Committee for Fluoride-Iodine Fortification of Salt, Swiss Academy of Medical Science, Bern, Switzerland.

Context: Pregnant women are often iron deficient, and iron deficiency has adverse effects on thyroid metabolism. Impaired maternal thyroid function during pregnancy may cause neurodevelopmental delays in the offspring. Objective: To investigate if maternal iron status is a determinant of TSH and/or TT4 concentrations during pregnancy Design and Outcome Measures: In a representative national sample of Swiss pregnant women (n=365) in the 2(nd) and 3(rd) trimester, samples of urine and blood were collected, and data on maternal characteristics and supplement use was recorded. Concentrations of TSH, TT4, hemoglobin, mean corpuscular volume, serum ferritin (SF), transferrin receptor (TfR) and urinary iodine (UI) were measured. Body iron stores were calculated and stepwise regressions done to look for associations. Results: The median UI (range) was 139 (30-433) microg/L. In the 3(rd) trimester, nearly 40% of women had negative body iron stores, 16% of woman had a TT4 <100 nmol/L and 6% had a TSH >4.0 mU/L. Compared to the women with positive body iron stores, the relative risk of a TT4 <100 nmol/L in the group with negative body iron stores was 7.8 (95% CI: 4.1; 14.9). Of the 12 women with TSH >4.0 mU/L, 10 of them had negative body iron stores. SF, TfR and body iron stores were highly significant predictors of TSH (standardized beta: -0.506, 0.602, and -0.589, respectively, all p<0.0001) and TT4 (standardized beta: 0.679, -0.589, and 0.659, respectively, all p<0.0001). Conclusions: Poor maternal iron status predicts both higher TSH and lower TT4 concentrations during pregnancy in an area of borderline iodine deficiency.

Ïîëíûé òåêñò äîñòóïåí [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Êîììåíòàðèè ê ñîîáùåíèþ:
EVP îäîáðèë(à):
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
 



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 07:34.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.